Taken together, these results suggest that CD133 regulates MDR through the expression of MDR1/P-gp, and the AKT-NF-κB signalling pathway is the main mechanism by which CD133 regulates MDR1/P-gp expression in CRC. Here, NFKB1 is linked to colorectal carcinoma.